Platelet aggregation inhibitors

Details Platelet aggregation inhibitors Platelet aggregation inhibitors

1995-06-07

1999-10-19

Davenport, Avis M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 15, 514 16, 530317, 530327, 530328, A61K 3800, C07K 500, C07K 700

Patent

active

059689021

ABSTRACT:
The isolated and purified PAI from several active snake venoms is described and characterized. In addition, PAIs lacking the Arg-Gly-Asp (RGD) adhesion sequence but containing K* -(G/Sar)-D wherein K* is a modified lysyl residue of the formula

REFERENCES:
patent: 4517686 (1985-05-01), Ruoslahti et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4589881 (1986-05-01), Pierschbacher et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4652639 (1987-03-01), Stabinsky
patent: 4661111 (1987-04-01), Ruoslahti et al.
patent: 4661471 (1987-04-01), Hawiger et al.
patent: 4683291 (1987-07-01), Zimmerman et al.
patent: 4792525 (1988-12-01), Ruoslahti et al.
patent: 4857508 (1989-08-01), Adams et al.
patent: 4992463 (1991-02-01), Troeng et al.
patent: 5023233 (1991-06-01), Nutt
patent: 5100875 (1992-03-01), de Rotrou
patent: 5338723 (1994-08-01), Nutt
patent: 5340798 (1994-08-01), Nutt
patent: 5374622 (1994-12-01), Nutt
Charon, et al., Synthetic Peptide with Antithrombotic Activity, Peptides, Chemistry, Structure and Biology, Proceedings of the Eleventh American Peptide Symposium, Jul. 9-14, 1989, La Jolla, CA, pp. 82-83.
Ginsberg, et al., Inhibition of Fibronectin Binding to Platelets by Proteolytic Fragments and Synthetic Peptides Which Support Fibroblast Adhesion, The Journal of Biological Chemistry, 260(7):3931-3936 (1985).
Hanson et al., Baboon Models of Acute Arterial Thrombosis, Thrombosis and Haemostatis, 58(3):801-805 (1987).
Hanson et al., Platelet Interaction with Dacron Vascular Grafts, Arteriosclerosis, 5:595-603 (Nov./Dec. 1985).
Huang et al., Mechanism of Action of the Platelet Aggregation Inhibitor Purified from Agkistrodon Halys (Mamushi) Snake Venom, Toxicon, 22:243-252 (1984).
Huang et al., Characterization of a Potent Platelet Aggregation Inhibitor from Agkistrodon Rhodostoma Snake Venom, Biochimica et Byophysica Acta 22789, 925:248-257 (1987).
Kosugi, et al., Isolation of Platelet Aggregation Inhibitor from Trimesurus Flavoridis Snake Venom, The Snake, 17:117-123 (1985).
Kumagai, et al., Effect of Cyclic RGD Peptide On Cell Adhesion and Tumor Metastasis, Biochemical and Biophysical Research Communications, 177(1):74-82 (1991).
Musial, et al., Inhibition of Platelet Adhesion to Surfaces of Extracorporeal Circuits by Disintegrins, Circulation, 82(1):262-273 (1990).
Niewiarowski et al., Inhibition of Platelet Adhesion to Surfaces of Extracorporeal Circuit by RGD Containing Peptides from Viper Venoms, Thrombosis and Haemostasis, 62:319, Abstract No. 853 (1989).
Nutt, et al., Development of Novel, Highly Selective Fibrinogen Receptor Antagonists as Potentially Useful antithrombotic Agents, Peptides, Chemistry and Biology, Proceedings of the Twelfth American Peptide Symposium, Jun. 16-21, 1991, Cambridge, MA, pp. 914-916.
Nutt, et al., Structure- and Conformation-Activity Studies Leading to Potent Fibrinogen Receptor Antagonists Containing Arg-Gly-Asp, Peptides, pp. 784-786 (1990).
Ouyang et al., A Potent Platelet Aggregation Inhibitor Purified from Agkistrodon Halys (Mamushi) Snake Venom, Toxicon, 21(6):797-804 (1983).
Samanen, et al., Development of a Small RGD Peptide Fibrinogen Receptor Antagonist with Potent Antiaggregatory Activity in Vitro, J. Med. Chem. 34:3114-3125 (1991).
Scarborough, et al., Barbourin A GPIIb-IIIa-Specific Integrin Antagonist from the Venom of Sistrurus M. Barbouri, The Journal of Biological Chemistry, 266(15):9359-9362 (1991).
Scarborough, Design of Potent and Specific Integrin Antagonists, J. Biol. Chem., 268:1066-1073 (1993).
Smith et al., Table 3.1 The Structures of the .alpha.-Amino Acids Commonly Found in Proteins, Principles of Biochemistry, 7th Edition, pp. 32-33, 1983, McGraw Hill.
Steiner et al., CA.sup.2+ -Dependent Binding of a Synthetic Arg-Gly-Asp (RGD) Peptide to a Single Site on the Purified Platelet Glycoprotein IIb-IIIa Complex, J. Biol. Chem., 264(22):13102-13108 (1989).
Ali et al., Structure-Activity studies Toward the Improvement of Antiaggregatory Activity of Arg-Gly-Asp-Ser (RGDS) Peptides: Chemistry, Structure and Biology (Proceedings of the 11th American Peptide Symposium), Marshall, G.R. and River, J.E. editors, ESCOM, Leiden (1990) pp. 94-96.
Bennett et al., Inhibition of Fibrinogen Binding Stimulated Human Platelets by a Monoclonal Antibody, Proc. Natl. Acad. Sci., 80:2417-2421 (1983).
Cadroy et al., RGDV Peptide Selectively Inhibits Platelet-Dependent Thrombus Formation In Vivo, J. Clin. Invest., 84:939-944 (1989).
Chao et al., Applaggin: A Potent Inhibitor of Platelet Aggregation and Secretion, Thrombosis and Haemostasis 62(1):50, Abstract No. 120 (1989).
Chao et al., Agkistrodon Piscivorus Piscivorus Platelet Aggregation Inhibitor: A Potent Inhibitor of Platelet Activation, Proc. Natl. Acad. Sci., 86:8050-8054 (1989).
Dennis et al., Platelet Glycoprotein IIb-IIIa Protein Antagonists from Snake Venoms: Evidence for a Family of Platelet-Aggregation Inhibitors, Proc. Natl. Acad. Sci., 87:2471-2475 (1989).
Gan et al., Echistatin, A Potent Platelet Aggregation Inhibitor from the Venom of the Viper, Echis Carinauts, J. Biol. Chem., 263(36):19827-19832 (1988).
Garsky et al., Chemical Synthesis of Echistatin, A Potent Inhibitor of Platelet Aggregation from Echis Carinatus: Synthesis and Biological Activity of Selected Analogs, Proc. Natl. Acad. Sci., 86:4022-4026 (1989).
Huang et al., Trigramin A Low Molecular Weight Peptide Inhibiting Fibrinogen Interaction with Platelet Receptor Expressed on Glycoprotein IIb-IIIa Complex, J. Biol. Chem., 262(33):16157-16163 (1987).
Huang et al., Trigramin: Primary Structure and Its Inhibition of von Willebrand Factor Binding to Glycoprotein IIb/IIIa Complex on Human Platelets, Biochemistry, 28:661-666 (1989).
Huang et al., Halysin, A Potent Platelet Aggregation Inhibitor, Inhibits the Fibrinogen Binding to the Activated Platelets, Thrombosis and Haemostasis 62(1):48, Abstract No. 112 (1989).
Kloczewiak et al., Platelet Receptor Recognition Domain on the .gamma. Chain of Human Fibrinogen and Its Synthetic Peptide Analogues, Biochemistry, 28:2915-2919 (1989).
Knudsen et al., Trigramin, an RGD-Containing Peptide from Snake Venom, Inhibits Cell-Substratum Adhesion of Human Melanoma Cells, Exerimental Cell Research, 179:42-49 (1988).
Nachman et al., Complex Formation of Platelet Membrane Glycoproteins IIb and IIIa with Fibrinogen, Amer, Soc. for Clin. Invest., 69:263-269 (1982).
Niewiarowski et al., Potential Application of RGD Containing Peptides from Viper Venoms (Disintegrins) in Antiplatelet Therapy, Thrombosis and Haemostasis, 62(1):319, Abstract No. SY-XIV-5 (1989).
Phillips et al., The Platelet Membrane Glycoprotein IIb-IIIa Complex, Blood, 71:831-843 (1988).
Pierschbacher et al., Influence of Stereochemistry of the Sequence Arg-Asp-Xaa on Binding Specificity in Cell Adhesion, J. Biol. Chem., 262:17294-17298 (1987).
Pierschbacher and Ruoslahti, Variants of the Cell Recognition Site of Fibronectin that Retain Attachment-Promoting Activity, Proc. Natl. Acad. Sci., 81:5985-5988 (1984).
Plow et al., Arginyl-Glycyl-Aspartic Acid Sequences and Fibrinogen Binding to Platelets, Blood, 70(1):110-115 (1987).
Plow et al., The Effect of Arg-Gly-Asp-containing peptides on Fibrinogen and von Willebrand Factor Binding to Platelets, Proc. Natl. Acad. Sci., 82:8057-8061 (1985).
Ruggeri et al., Inhibition of Platelet Function With Synthetic Peptides Designed to be High-Affinity Antagonists of Fibrinogen Binding to Platelets; Proc. Natl. Acad. Sci. USA, 83:5708-5712 (1986).
Rucinski et al., Batroxostatin, A RGD Containing Peptide from B. Atrox Venom, is a Potent Inhibitor of Cell Interaction with Adhesive Proteins, Thrombosis and Haemostasis, 62:50, Abstract No. 1560 (1989).
Ruoslahti et al., New Perspectives in Cell Adhesion: RGD and Integrins, Science, 238:491-497 (1987).
Ruoslahti et al., Arg-Gly-Asr: A Versatile Cell Recognition Signal, Cell, 44:517-518 (1986).
Samanen et al., An RGD-Peptide Analog with Potent Antithrombotic Activity In Vivo, J. Cell. Biol. Supplement 14A:A229 (1990).
Shebuski et al., Characterization and Platelet Inhibitory Activity of Bitistatin, a Potent Arginin

Affiliated with

Also associated with

Rating

Platelet aggregation inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Platelet aggregation inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet aggregation inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2055426